Skip to content

Investigating the Effect of Lavender on the Level of Sedation in Hospitalized Children in the ICU

Investigating the inhalation effect of lavender essential oil on sedation levels in children hospitalized in the intensive care unit (ICU)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT20101220005426N15
Enrollment
70
Registered
2026-05-14
Start date
2026-05-31
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Agitation rate. Anxiety disorder, unspecified

Interventions

Intervention 1: Intervention group: In the intervention group, in addition to the routine care provided in the intensive care unit (for controlling anxiety and agitation, which includes the use of sed

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: Age 12 to 18 years GCS greater than or equal to 8 Admitted to intensive care units (ICU) Patient extubated at the time of study entry Hemodynamic stability No known history of hypersensitivity to lavender or other aromatic herbal compounds No history of chronic respiratory diseases No clinical signs or diagnosis of active pulmonary aspiration No primary or secondary immunodeficiency disorders Having a normal sense of smell Written informed consent from the patient’s parent or legal guardian

Exclusion criteria

Exclusion criteria: Patient intubation Transfer of the patient to other units Patient death Sudden and significant changes in hemodynamic status Occurrence of any side effects

Design outcomes

Primary

MeasureTime frame
Aromatherapy. Timepoint: At the beginning and end of the intervention. Method of measurement: Charted information.;RASS (Richmond Agitation-Sedation Scale) SCORE. Timepoint: At 0, 6, 12, 18, and 24 hours after the start of the intervention. Method of measurement: RASS table.

Secondary

MeasureTime frame
BMI. Timepoint: At the beginning of the intervention. Method of measurement: File information.;Age. Timepoint: At the beginning of the intervention. Method of measurement: File information.;Gender. Timepoint: At the beginning of the intervention. Method of measurement: File information.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Ahmadinejad

Kerman University of Medical Sciences

m.ahmadinejad@kmu.ac.ir+98 34 0223 5011

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026